Industry

non-CME

Immuno-Oncology

Replimune Industry Spotlight Session: Oncolytic Immunotherapy: Past, Present, & Future

Faculty(s)

• 

  David Cohan, MD/FSSO (he/him/his)

  Executive Director, Clinical Development
  Replimune, Inc.

  Disclosure information not submitted.